Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital

Sophie D Fosså1 National Resource Center for Late Effects after Cancer Treatment, Norwegian Radium Hospital, Oslo University Hospital, Radiumhospital, Oslo, NorwayCorrespondence[email protected]

Siri L Hess1 National Resource Center for Late Effects after Cancer Treatment, Norwegian Radium Hospital, Oslo University Hospital, Radiumhospital, Oslo, Norway

Elisabeth Paus2 Department of Medical Biochemistry, Norwegian Radium Hospital, Oslo University Hospital, Radiumhospital, Oslo, Norway

Elin Borgen3 Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Radiumhospital, Oslo, Norway

Pages 121-126 | Published online: 27 Sep 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

HalabiSVogelzangNJKornblithABPain predicts overall survival in men with metastatic castration-refractory prostate cancerJ Clin Oncol200826152544254918487572
PubMed Web of Science ®Google Scholar
HalabiSSmallEJKantoffPWPrognostic model for predicting survival in men with hormone-refractory metastatic prostate cancerJ Clin Oncol20032171232123712663709
PubMed Web of Science ®Google Scholar
FossåSDDearnaleyDPLawMGadJNewlingDWTveterKPrognostic factors in hormone-resistant progressing cancer of the prostateAnn Oncol1992353613661616889
PubMed Web of Science ®Google Scholar
SmaletzOScherHISmallEJNomogram for overall survival of patients with progressive metastatic prostate cancer after castrationJ Clin Oncol200220193972398212351594
PubMed Web of Science ®Google Scholar
HalabiSLinCYSmallEJPrognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapyJ Natl Cancer Inst2013105221729173724136890
PubMedGoogle Scholar
OlmosDArkenauHTAngJECirculating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experienceAnn Oncol2009201273318695026
PubMed Web of Science ®Google Scholar
ScherHIJiaXde BonoJSCirculating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataLancet Oncol200910323323919213602
PubMed Web of Science ®Google Scholar
GoldkornAElyBQuinnDICirculating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancerJ Clin Oncol2014321136114224616308
PubMed Web of Science ®Google Scholar
OmlinAPezaroCMukherjiDImproved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomogramsEur Urol201364230030623313031
PubMed Web of Science ®Google Scholar
FossåSDSleePHBrausiMFlutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupJ Clin Oncol2001191627111134196
PubMed Web of Science ®Google Scholar
FossåSDJacobsenABGinmanCWeekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II studyEur Urol20075261691169817306441
PubMed Web of Science ®Google Scholar
MeulenbeldHJvan WerkhovenEDCoenenJLRandomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)Eur J Cancer201248162993300022677260
PubMed Web of Science ®Google Scholar
ParkerCNilssonSHeinrichDALSYMPCA InvestigatorsAlpha emitter radium-223 and survival in metastatic prostate cancerN Engl J Med2013369321322323863050
PubMed Web of Science ®Google Scholar
MolloyTJBosmaAJBaumbuschLOThe prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patientsBreast Cancer Res2011133R6121672237
PubMed Web of Science ®Google Scholar
MathiesenRRBorgenERenolenAPersistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survivalBreast Cancer Res2012144R11722889108
PubMed Web of Science ®Google Scholar
SeebergLTWaageABrunborgCCirculating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired SurvivalAnn Surg Epub262014
Web of Science ®Google Scholar
AllardWJMateraJMillerMCTumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseasesClin Cancer Res200410206897690415501967
PubMed Web of Science ®Google Scholar
de BonoJSLogothetisCJMolinaACOU-AA-301 InvestigatorsAbiraterone and increased survival in metastatic prostate cancerN Engl J Med20113641995200521612468
PubMed Web of Science ®Google Scholar
RyanCJSmithMRde BonoJSCOU-AA-302 InvestigatorsAbiraterone in metastatic prostate cancer without previous chemotherapyN Engl J Med2013368213814823228172
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date